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Abstract
Background: Stigma is a known barrier to HIV testing and care. Because access to antiretroviral therapy reduces
overt illness and mortality, some scholars theorized that HIV-related stigma would decrease as treatment availability
increased. However, the association between ART accessibility and stigma has not been as straightforward as
originally predicted.
Methods: We conducted a “situational analysis”—a rapid, community-based qualitative assessment to inform a
combination HIV prevention program in high prevalence communities. In the context of this community-based
research, we conducted semi-structured interviews and focus groups with 684 individuals in four low-resource
sub-districts in North West Province, South Africa. In addition to using this data to inform programming, we
examined the impact of stigma on the uptake of services.
Results: Findings suggested that anticipated stigma remains a barrier to care. Although participants reported less
enacted stigma, or hostility toward people living with HIV, they also felt that HIV remains synonymous with
promiscuity and infidelity. Participants described community members taking steps to avoid being identified as
HIV-positive, including avoiding healthcare facilities entirely, using traditional healers, or paying for private doctors.
Such behaviors led to delays in testing and accessing care, and problems adhering to medications, especially for
men and youth with no other health condition that could plausibly account for their utilization of medical services.
Conclusions: We conclude that providing access to ART alone will not end HIV-related stigma. Instead, individuals
will remain hesitant to seek care as long as they fear that doing so will lead to prejudice and discrimination. It is
critical to combat this trend by increasing cultural acceptance of being seropositive, integrating HIV care into
general primary care and normalizing men and youths’ accessing health care.
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Background
Stigma has been cited as a key driver of the HIV epi-
demic. As stigma acts as a mechanism to reinforce exist-
ing power structures, HIV’s association with debilitation,
death, lost capacity to work, and behavior that may be
deemed socially ‘deviant’ has allowed HIV-related stigma
to be especially pernicious and long-lasting [1–3]. HIV-
related stigma has hindered intervention efforts, led to
delays in testing, reduced engagement in care, and low-
ered adherence to treatment and care regimens [3–9].
Increased access to antiretroviral therapy (ART) has
greatly reduced the disease’s fatality rate and allowed
people living with HIV (PLHIV) to maintain their social
and economic roles within their families and communi-
ties. Many practitioners, activists, and researchers theo-
rized that the improved access to treatment would
subsequently lead to the decline of HIV-related prejudice
and discrimination [10–12]. This hypothesis is predi-
cated on people having reasonable access to treatment
and on anticipations of stigma not acting as an initial
barrier to obtaining treatment. Indeed, the actual associ-
ation between the introduction of ART and stigma, has
not been as straightforward as originally predicted.
Although the rollout of ART was followed by reductions
in HIV-related prejudicial attitudes in many African coun-
tries [13, 14], recent studies also suggest that stigma per-
sists and continues to be a barrier to HIV treatment and
care [15]. Considering stigma’s varied manifestations can
help further elucidate these findings. The most readily
apparent form, enacted stigma, consists of acts of discrim-
ination perpetrated against someone who has or is per-
ceived to have a scorned condition [16, 17]. Other forms
are less obvious because they principally involve individual
beliefs. Internalized stigma refers to a person’s own en-
dorsement of prejudicial beliefs about a devalued charac-
teristic [16, 18, 19]. When the person endorsing such
beliefs is from the devalued group, internalized stigma ef-
fectively becomes a form of self-stigma. By contrast, antic-
ipated stigma refers to beliefs that others hold prejudicial
beliefs about a devalued group and that they may discrim-
inate against that group [20]. The introduction of ART
would most plausibly affect enacted or internalized stigma.
It is possible, however, that people may continue to an-
ticipate the possibility of stigma and take steps to avoid it
[15, 16]. Such dynamics would have important implications
for how best to address HIV-related stigma in order to in-
crease engagement in HIV care.
We examined community perceptions of stigma and
sought to understand if and how these perceptions influ-
ence people’s engagement with HIV prevention and
treatment within the context of expanding access to
ART at four sites in two high prevalence districts in the
North West Province of South Africa [21, 22]. The Re-
public of South Africa, which has the highest number of
people living with HIV (6.4 million) and the second
highest number of HIV-related deaths in the world, has
undertaken mass HIV testing campaigns and decentra-
lized and expanded access to ART [23–25]. South Africa
now operates the world’s largest antiretroviral program
[26] and has significantly improved access to condoms,
HIV testing, and treatment [27]. HIV testing is being in-
tegrated into primary care and ART is now available in
almost all local health clinics and with broadened eligi-
bility criteria (lifetime treatment for pregnant women,
tuberculosis (TB) co-infection and increased qualifying
eligibility to CD4 ≤ 500 cells/mm3 from previous 350
cells/mm3). However, huge gaps in testing and treatment
remain. Data from 2012 indicate that only 37.8 % of
HIV-positive men and 55 % of HIV positive women were
aware of their HIV status [23]. Nationally it is estimated
that only half of ART eligible patients are currently on
treatment [28]. It is thus imperative to understand why
people are not linking to or remaining in care and what
role stigma continues to play regarding prevention and
treatment.
Methods
We conducted a secondary data analysis on data col-
lected as part of the rapid community-based qualitative
assessment to inform a combination HIV prevention
project being conducted in the Bojanala Platinum and
Dr. Ruth Segomotsi Mompati Districts of South Africa
[21, 22]. The primary purpose of the research was to en-
gage community members and stakeholders and tailor
intervention activities to the local context prior to pro-
gram implementation. To do so, a situational analysis
was conducted. Situational analysis is a type of rapid as-
sessment that provides a snapshot of the epidemic in
context, and includes a review of available data, explor-
ation of new data, and triangulation of the varied data
sources, relying heavily on interpretive help of local
stakeholders. Further the methods’ data collection and
analysis balances gathering a breadth and depth of data
while adhering to a short timeframe. In today’s context
of diminishing resources for health programming, rapid
assessments provide an efficient means to improve the
efficacy and acceptability of targeted HIV prevention
programs [29, 30]. One week of rapid data collection, in-
cluding in-depth-interviews (IDIs), focus group discussions
(FGDs), and health facility assessments, was conducted in
each site between April 2012 and September 2013. Details
on methods and results, including impact on program de-
sign, are described elsewhere [21, 22].
Study sites
The situational analysis was undertaken in four sub-
districts in North West Province, which has the fourth
highest HIV prevalence in the country (estimated at
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30.2 % in the antenatal setting [31]). Study sub-districts
were selected for inclusion by South Africa Department
of Health collaborators. Generally, the sites are charac-
terized by poverty, unemployment, and low literacy
levels, however industry and population density in the
study areas varied from the urban Rustenburg sub-
district, home to the platinum mining industry and rapid
population growth, to Lekwa Teemane sub-district, a
compact rural area dominated by farming.
Data collection team
Data was collected by a team of up to 11 trained clini-
cians, social scientists, epidemiologists, program staff,
and government officials. Training included ethics, con-
fidentiality and consent procedures; orientation to study
goals and data collection instruments; interviewing, fa-
cilitating, and note taking skills; documentation and data
management procedures; and analysis skills. Team mem-
bers who were new to qualitative research were paired
with more experienced researchers for the first few days
of fieldwork.
Recruitment & eligibility
Following stakeholder meetings in each sub-district, the
data collection team spent one week at each site visiting
health and social service locations, non-governmental
organizations (NGOs), and areas where vulnerable and
mobile populations congregate, such as truck stops, taxi
ranks, taverns, and informal settlements. Facility assess-
ments were conducted at all health facilities in the two
smaller sub-districts and at a purposefully sampled, di-
verse subset of health facilities in the two larger sub-
districts. For interviews and focus groups, teams spoke
with key informants (e.g. government officials, employers,
and community leaders), health care providers, and com-
munity members (Table 1). Participants were selected
through a combination of convenience and purposeful
sampling, based on stakeholder recommendations. People
were eligible to participate if they were age 18 years or
older, spent time in the respective sub-district, were not
under the influence of drugs or alcohol, and were able and
willing to consent. Written informed consent preceded all
interviews; consent and interviews were conducted in
English, IsiXhosa, IsiZulu or Setswana, based on partici-
pant preference. All procedures were approved by the
Committee for Human Research at the University of
California, San Francisco (UCSF), and the Human
Sciences Research Council (HSRC) Research Ethics Com-
mittee in South Africa. As this data collection was per-
formed to inform the development of a non-research
intervention, the Human Subjects Division at University
of Washington and CDC’s Center for Global Health
Table 1 Number of participants in interviews, focus groups and assessments, by place and type
Naledi Moses Kotane Lekwa Teemane Rustenburg Total
Type Description Number of participants
Provider interview Nurses, facility managers, doctors, pharmacists,
HIV counselors, social workers, lab technicians
and data capturers.
33 26 21 18 98
Key informant interview Farm (Naledi) and mine management
(Moses Kotane), social development workers,
non-governmental organizations (NGOs), home
based carers, traditional healers, traditional
leaders, ward councillors, Department of
Health (DOH) officials, religious leaders and
tavern owners.
38 22 37 24 121
Community member interview Young adults (18–35), sex workers, mobile
workforce (e.g. truck drivers), migrant
populations, people living with HIV, church
members, tavern clients, farm workers (Naledi,
Lekwa Teemane), mine workers (Moses Kotane,
Rustenburg), people living in informal
settlements, men who have sex with men,
self-identified lesbian, gay, bisexual, or
transgender individuals.
57 32 68 57 214
Focus group Primarily community members sharing a
common characteristic (occupation, youth,
religion, etc.); also included some key
informants such as home based care workers
and NGO staff.
63 70 50 68 251
Number of facilities
Facility assessment Clinics, community health centers, hospitals,
roadside clinics and mobile clinics.
4a 8 7a 8 27
arepresents all clinics in the sub-districts, exclusive of hospitals
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Human Research Protection determined that the study
did not meet the regulatory definition of research under
45 CFR 46.102(d).
Interviews, focus groups and facility assessments
Semi-structured interview guides included questions
regarding community characteristics, mobility, employ-
ment, health challenges, TB and HIV-related services,
stigma related to HIV or TB, sexual partnerships, and
suggestions for health programming in the area. Each
guide had a specific section on HIV-related stigma; ex-
ample questions included “What kinds of challenges do
people living with HIV face in this community?” and “If
you were HIV positive, would you talk about it with
other people? Why/Why not?” No participant was asked
their HIV status, although many voluntarily shared it. As
we did not systematically collect data on participant’s
HIV status, we did not formally include participant HIV
status in our analysis. Health facility assessments were
conducted to document local health resources and gaps
in services. For the present analysis, we utilized facility
assessment variables that emerged as being directly rele-
vant to exacerbating (or not) stigmatization of people
living with HIV (PLHIV) in the clinic setting, such as
confidentiality procedures, infrastructure, auditory and
visual privacy, sufficient staffing levels, and data manage-
ment systems.
The study team took detailed field notes of each inter-
action and recorded interviews when participants con-
sented to be recorded. All field notes were recorded in
English, regardless of the language of the interview or
focus group, with the study team simultaneously trans-
lating for their field notebook as needed. Facility assess-
ment data was recorded on a standardized form with
room for researcher notes and observations.
Data analysis
Our data analysis process included two main phases of
analysis. The first phase was an iterative analytic process
undertaken in the field by the entire data collection team
(conducted by STK, LN, RH, SAL, JMG) [21, 32]. The
entire fieldwork team met at the end of each data collec-
tion day to discuss findings, pinpoint unanswered ques-
tions or knowledge gaps, offer new leads, and prioritize
subsequent interviews. By the end of the week, the re-
search team had agreed on the principal themes that
were emerging from the data, on key venues and areas
to focus prevention efforts, and on key questions that re-
quired further investigation [21]. These principal themes
formed our initial analytical and coding framework.
The second phase of data analysis commenced upon
returning from the field. This subsequent analysis (con-
ducted by STK, RH, HG) consisted of reviewing meeting
notes and coding original textual data from the fieldwork
notebooks. For the present analysis, we utilized the codes
of stigma, HIV-related concern and awareness, condom
use, testing, disclosure, treatment, barriers to accessing care,
and communication. All interview notebooks were coded
by hand (STK) and recordings were referenced whenever
questions arose based on the notes or as quotes were
needed. As the main purpose of data collection was pro-
gram planning and a significant proportion of the analysis
was conducted while in the field, only a small number
(n = 31) of interviews and focus groups were transcribed
for analysis in ATLAS.ti (ATLAS.ti Scientific Software
Development GmbH, Berlin, Germany). This included in-
terviews with 13 key informants, 10 providers, four com-
munity members, and four FGDs (with 25 community
member participants). Interviews were chosen for tran-
scription purposefully to ensure inclusion of key informa-
tion from informants when language of interview made it
difficult to cull important themes from mixed language
notes (as all handwritten notes were analyzed) and for
under-represented groups in the data.
Code reports were generated and reviewed. Based on re-
view of the deductively coded data (both transcripts and
notes), the authors (STK, WTS, SAL) developed inductive
codes to organize data on themes that emerged within
transcripts and interview notes and across the topics. All
interview notes were re-read to cross-check findings and to
ensure representation from all data collected. Authors
(STK, WTS, SAL) discussed and clarified the main ideas
that emerged and explored relationships within the data
among themes [33, 34]. Data from facility assessments were
summarized and compared to findings from the interviews.
We interpret and present the data in the aggregate because
the major themes did not differ across sub-districts or sub-
populations, except where specifically noted.
Results
Across the four sites, 684 participants, including key in-
formants, providers, and community members, partici-
pated in in-depth interviews (433) and focus groups
(251). Twenty-seven facility assessments were conducted
(Table 1). A little more than half of the participants were
female. Specific data on other identifiers, such as age or
HIV status, were not recorded.
In the sections that follow, we describe our findings
on the manifestations of stigma, how people attempt to
avoid disclosure, the resulting impact on engagement in
care, and strategies to overcome stigma’s effects. Table 2
provides a brief overview and examples from our results.
The impact of increased availability of ART
As respondents reflected back on the course of the HIV epi-
demic in their community, they reported that HIV-related
deaths were much less common than in the past and re-
ported increasing acceptance of HIV. Many participants
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used similar language to describe HIV’s transition from a
“death sentence” to a “chronic disease, just like diabetes” that
could be managed now that treatment is available.
“I think the scourge of HIV and AIDS is the one that's
– it has had a terrible impact in the past. It's now
quieter…" [#1, key informant, male, site #1]
“Like myself, everyone was afraid. Before it was a life
sentence, you were going to die. Everyone was
panicking—it was horrible. Now, if you know your
status you are going to get help.” [#2, key informant,
female, site #4]
Providers, people living with HIV who were taking
part in support groups, those who worked with NGOs
delivering HIV-related services, and those in the urban
areas were most likely to regard HIV-related enacted
stigma as declining. Community members also reported
declining discrimination, with most narratives describing
improvement, but not resolution, in how individuals
with HIV infection were treated.
“Everybody is starting to accept HIV. Even though
stigma is still there, it’s very little. It’s not like before…
It’s not that they would hate you…but it’s like ‘I don’t
want to be with this person as my partner, who is HIV
positive.’” [#3, community member, male, site #4]
HIV remained highly associated with promiscuity and
adultery, however, and prejudicial beliefs were still
reported:
“[A]nd of course, people always look at [HIV] as a moral
issue. That's why you find someone who – you know,
who is infected would feel they should hide it, because
when people talk about this, they would always be
saying it's people that behave in this fashion, or that
fashion. Like people that are promiscuous and all of
that.” [#4, key informant, male, site #1]
Informants spoke at length about continuing negative
social consequences of living with HIV. They noted that,
even though enacted stigma may be less severe than be-
fore, HIV positive community members could still be
treated differently or socially isolated, both from the
general community and from family.
“They just shun you. Today they like you, but stigma is
a problem because sometimes if somebody finds out
I’m HIV positive, the treatment will never be the same
again.... tomorrow you're not one of them.” [#5, key
informant, female, site #1]
“Now he thinks that person doesn’t have to eat with
my spoon, doesn’t have to wash my dishes. Doesn’t
have to sleep with us, he have to sleep alone. That is
making a stigma, and that’s why I think most of the
people they died because of that.” [#6, focus group
member, female, site #1]
Participants also reported feeling stigmatized by
healthcare providers. This was especially common
among key populations: youth, sex workers, and men
who have sex with men (MSM). Healthcare workers
themselves were impacted by concerns of facing
stigmatization while receiving care, with some key infor-
mants and facility managers reporting that healthcare
workers didn’t seek care for fear of their colleagues’
reactions. “It’s sad that some [clinic] staff will die due to
lack of being monitored. This is a serious challenge.” [#7,
key informant, female, site #4]
Table 2 Disclosure risks, impacts to engagement in care and
mechanisms to avoid disclosure
The impact of increased availability of ART
Fewer HIV-related deaths reported, HIV has transitioned from a “death
sentence” to a chronic disease
HIV-related stigma declining but still present
HIV remains highly associated with promiscuity and adultery
Efforts to control knowledge about a person’s HIV infection
Avoided disclosure for fear of abandonment or prejudice
“Counterfeiting,” or citing TB, other illnesses or witchcraft as cause of
illness instead of HIV, a common way to avoid disclosure
Did not take treatment to avoid explaining need for medications to
family or people they are living with
Seeking care is in conflict with keeping HIV status private
Being seen at the clinic (for any reason) caused suspicion of HIV or
gossiping; this significantly delayed HIV testing or engagement in
care and was especially problematic for youth and men
Home based care workers visiting a house could signal to neighbors
that someone was HIV positive; false contact information given or
care from home based care workers was refused
Clinic infrastructure such as HIV specific rooms, filing systems,
different colored folders and coding systems revealed HIV status to
other patients
There was a severe distrust of health care workers breaking
confidentiality, partially fuelled by patients knowing nurses at local
health facilities
Attempts to increase engagement to care and combat stigma met
with varying success
Reduced initiation of treatment or adherence because treatment had
to be picked up at clinics.
Community members spend more money and/or time to go to a
private doctor or attend facilities in a different community
Clinics tried to facilitate support groups or encourage an ART
“supporter” for PLHIV—these were met with varying success
Male dominated spaces (i.e. mine health facilities & truck stop clinics)
were more successful in engaging men in care
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Efforts to control knowledge about a person's HIV infection
Though the general consensus was that HIV enacted
stigma was not as extreme as it once had been, partici-
pants universally reported that most HIV-positive men
and women did not disclose their HIV status for fear of
social ostracism (i.e., anticipated stigma). Participants re-
ported that disclosure to partners could lead to breaking
up or abandonment, blame, accusations, and violence.
Participants reported fears that family members might
ostracize individuals who revealed their HIV status or re-
fuse to accept that the person is HIV-positive.
“If I was positive, I would never disclose. People attack
your background; you don’t get support” [#8, key
informant, female, site #3]
“I can say that [their HIV status] is a person's secret
because eh…sometimes when other people know they
ridicule you or on and on. Now that is why it is a secret…
because it is said even if the doctor knows it becomes
yours and the doctor's [secret]…there is no need to tell
anybody…” [#9, community member, male, site #2]
Participants consistently reported that PLHIV use
strategies to manage who learns of their HIV status.
Many participants reported PLHIV prefer to “counterfeit”
[35, 36] or pass off their HIV infection as being something
else to avoid disclosing their HIV status. For example, one
participant was interviewed at a heath facility where he
had gone to collect his ART refill. He had told his family
that he was going to the clinic to get treatment for a re-
cent car accident. More often, TB was used as the alter-
nate explanation for their health problems, although it too
is stigmatized to a lesser degree.
“People know that they died of HIV but they shield it –
TB, TB, TB” [#10, key informant, female, site #3]
“People who had TB in the past never used to disclose
it because of the stigma. But it has shifted to HIV. So
everybody who is HIV positive, they won’t say I’m HIV,
they will say that I’ve got TB. So TB’s a better disease
than HIV because they know TB can be cured. But
HIV cannot.” [#11, key informant, female, site #1]
Participants also turned to the common belief in be-
witchment or “makgome,” a disease without cause, and
the use of traditional healers as a means of concealing
their HIV infection and avoiding the clinic:
“This person will know that ‘I’m HIV positive’. But
already everybody in the family thinks its makgome.
So it is very difficult for this person to disclose. Because
how is he or she going to tell them that, ‘I’m HIV
positive’?” … Its denial but also coping.” [#11, key
informant, female, site #1]
Participants relayed significant adherence challenges
due to reluctance to disclose to partners, family or friends.
It was common to have many people living in the same
house, which complicated efforts to take medications dis-
creetly. One participant spoke of an HIV-positive man
who came regularly to collect his medications and even
participated in pill counts to ensure adherence. When he
died, his family members, to whom he had not disclosed,
found all of his pills underneath his bed. A lack of family
support and sense of isolation further decreased people’s
abilities and desires to seek care or adhere to treatment.
“Lots of people are dying because they can’t go out and
talk.” [#12, community member, female, site #3]
Seeking care is in conflict with keeping HIV status private
Participants reported that simply being seen at a health
clinic meant risking exposure of one’s HIV status. This
perception was considered to be a major barrier to
accessing health facilities for testing or treatment and a
reason for delaying access to care until extremely sick.
“Cuz they think…you will see him go to the clinic and
maybe you will think that, ‘Oh, he has the HIV and
AIDS’.” [#13, community member, female, site #1]
“I still believe that there is the issue of stigmatization, we
see a major problem because we find that that…some of
these people come [to clinic] when they are in the last
stage [of disease].” [#14, provider, male, site #2]
This barrier manifested itself differently for men and
women. Participants reported that men were much more
likely to wait to seek care until they were very sick. This
difference was due in part to local notions of masculin-
ity, which disfavor seeking help because it is thought to
be a sign of weakness.
Focus Group Member 1 (male): “I’ll refer to boys
specifically. It seems like their dignity is going to fall
being seen entering a clinic or something…or a hospital.”
Focus Group Member 2 (female): “There is the
concept that the clinic is only for females.”
Focus Group Member 1: “[This idea] has passed on
from one generation to the other.” [#15, focus group for
youth, site #3]
Men felt at risk of being stigmatized because being
sick and attending a clinic “for females” was considered
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a deviation from the ideal notions of masculinity. The
gender difference was also tied to broader variations in
why men or women would be seeking services at a clinic
in the first place. Women have an easier time accessing
regular care for HIV because they can do so under the
guise of reproductive health services, pregnancy, or chil-
dren’s health care needs. Men and youth, by contrast, do
not have the same clinical reasons to be seen at a health
care facility, and their attendance could lead to gossip. For
youth, the situation was further complicated by fear that
someone would tell their parents they were at a facility.
“But to see people who go out of their free will [to test for
HIV], especially males, I find it rare. I think with
males…my assumption is that people think they are
healthy or the man is worried to find out [his HIV
status], you see. But you know with women, when you're
pregnant you go, you test. When they go for their
prevention contraceptives, they are tested. With females
I find they have the tendency of knowing they can go
and test any time.” [#16, key informant, male, site #1]
Providers reported that fear of stigmatization also led
patients to give incorrect contact information to prevent
the health facility from contacting them for treatment or
additional tests. Respondents reported that family mem-
bers sometimes prevented home-based care workers from
visiting sick relatives because they did not want neighbors
to know that someone in the house had HIV, as home
based care workers wore uniforms and were therefore
easily identifiable. A home based care worker reported:
“Maybe it’s few of them that ignore it and they’re
scared to tell other people, even me, the [caregiver],
and they can’t talk to me and say, ‘Hey, sister. I’ve got
this. What can I do? And I need help.’ They ignore it
and at the end of the day, is dying.” [#6, focus group
member, female, site #1]
Infrastructure also played a role in keeping PLHIV from
accessing care due to fears of disclosure. Informants re-
ported, and study staff observed, extremely full facilities
with long wait times and physical infrastructure not de-
signed to serve such a high patient load. As with many rural
areas, recruiting and maintaining staff was also a significant
challenge [37]. Staffing levels were reported to be insuffi-
cient to meet the needs of the local population at 22 of the
27 (81 %) health facilities assessed. As a result, some clinics
attempted to see patients more efficiently by instituting sep-
arate waiting areas and consulting rooms for HIV testing to
streamline the care process. Some facilities also imple-
mented specific days of the week for specific health issues,
e.g. Thursdays were for patients with “chronic” conditions,
which includes HIV-positive patients. This euphemism was
not lost on the community. One community-member ex-
plained that a separate building was used at one clinic to
dispense ART to HIV positive patients:
“[That building] is in the same yard [as the clinic] so
obviously people see you going there [to collect
treatment] and that causes defaulting [i.e., not adhering
to ART medication regimens].” [#17, community
member, female, site #4]
Further, data management practices lacked uniformity
and easily revealed the HIV status of patients. Of the 14
facilities where the field team specifically compared
medical record keeping practices for HIV positive versus
other patients, 11 (73 %) used different file labels, folder
colors, or storage systems for HIV patient files. Although
these practices were instituted for non-stigmatizing rea-
sons, such as a lack of space or a desire for greater effi-
ciency, they were seen by participants as a potential
means by which a patient’s confidentiality could be unin-
tentionally violated and his/her HIV status disclosed.
Participants also reported that many community mem-
bers were reluctant to be tested for HIV or receive HIV
care at local clinics out of fear that healthcare staff
would reveal their status. Some participants could not
point to specific examples of confidentiality breaches,
but still described wariness of clinical environments.
Others were able to cite specific examples of breaches,
with a handful of key informants even reporting that
they had misused their own access to health records to
look up the status of someone they knew to be sick. One
key informant reported:
“Recently someone (a health care provider)…was drunk…
and said that our village is full of people who are HIV-
positive and that [s/he] could even expose them by their
names. This person even mentioned another family by
name. As a result many are scared to get their treatment…
because they do not want their names spread all over
the place.” [#18, key informant, female, site #2]
Fear of health worker gossip was particularly keen in
rural areas and smaller towns—“In a small town, everyone
knows everything.” [#19, key informant, female, site #3]
Facility assessment data confirmed insufficient atten-
tion to confidentiality. Of the 26 facilities accessed, 14
(54 %) reported not having a confidentiality policy; 6
(23 %) of the facilities produced a written confidentiality
policy for the field staff; and the remaining 6 (23 %) re-
ported having a policy but couldn’t not produce the ma-
terials to the field staff.
“What they tend to say is that I don't want to test at
the clinic because I know the counselor and if she finds
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out I’m positive she'll probably go tell my friends. …So
that's why you'd find that some of the people that do
test don't even test in the community.” [#5, key
informant, female, site #1]
Attempts to increase engagement to care and combat
stigma met with varying success
The perceived risks of being seen at the clinic, having HIV
status effectively disclosed through clinic practices (e.g.,
HIV-specific waiting rooms), or gossip by healthcare
workers led many patients to either not seek services or to
receive them in distant communities, despite the fact that
transportation to and from distant facilities was a signifi-
cant challenge. In areas where private health care was
available, participants also reported spending money to re-
ceive treatment in a more confidential setting instead of
utilizing the free care at the public health facilities.
Providers in some areas have launched efforts to in-
crease engagement in care, for example, by establishing
support groups. Participants in those groups reported
beneficial effects. “It kills you if you keep it in your heart. It
will hurt you. It’s better to share these things together.”
[#20, community member, female, site #1] However, infor-
mants also noted that the support groups were of limited
impact and hard to sustain because many people were
afraid of being stigmatized if they participated. Other
health facilities strongly encouraged HIV-positive patients
to bring a “supporter”—a friend or family member who
will help them adhere to treatment—to the clinic at the
time of ART initiation. Some participants felt this practice
dissuaded those who are not ready to disclose from
returning to the clinic or beginning treatment.
Some efforts were designed specifically to increase the
proportion of men in care. For example, a couple of
areas had small clinics that operated at night at truck
stops and employed ‘peer educators’ to recruit truck
drivers. Although the subset of patients reached was
modest, it consisted almost entirely of men. In addition,
at some large mines, employees were required to
complete health screenings when first hired and when
returning from long leaves, a practice that gave men a
reason for being seen at a healthcare facility. HIV testing
was offered during this process.
Discussion
We found that increased accessibility of ART had a posi-
tive impact in the community and that reports of
enacted stigma were on the decline, but still present. In
contrast to theories predicting that stigma would dissi-
pate once PLHIV had access to effective treatment
(because HIV would no longer be associated with death
and lost economic productivity) [9–12], community per-
ceptions of anticipated stigma persisted. This persistence
meant that the current, dominant primary outcome of
stigma was PLHIV hiding their HIV status from others.
This desire to conceal HIV status, or to manage antici-
pated stigma, was, in turn, a hindrance to engaging in
care in this high prevalence, rural setting. These findings
help to refine our understanding of the role of stigma in
a country where improvements to ART access are on-
going, and to explain differences observed in other re-
search. Prior study results were mixed on the continuing
impact of stigma. For example, stigma has been shown
to be a major barrier to initiating treatment [38]. But
after initiation, stigma has no impact on whether clients
discontinue their medications [39]. Instead, ART initi-
ation leads to increased support [9]. Our data explain
why all of of these things can be simultaneously true. As
reflected in the findings, a major impact of stigma comes
from what a person fears might happen, which in turn
dissuades people from seeking treatment. Once engaged
in care, however, the impact of stigma is less straightfor-
ward and likely to be dependent on the specific context
in which a person accesses care and the reactions a per-
son receives from others. Given that community mem-
bers’ hostile attitudes toward HIV have lessened, some
people living with HIV may find that prejudice and dis-
crimination are not as big of problems as they had
feared. As a result, these individuals are then able to re-
main engaged in care and to identify support among
friends and family.
The shift in the dominant manifestation of stigma
(from enacted to anticipated) is in line with predictions
from classic stigma theory [40]. Access to ART reduces
overt signs of HIV infection, effectively changing the dis-
ease from a discredited (readily apparent) to a discredit-
able (hidden) stigmatizing condition [40]. As a result,
PLHIV are now less likely to encounter enacted discrim-
ination because they pass as HIV-uninfected in many so-
cial situations. Furthermore, the declines in enacted
stigma are likely reinforced by the continuing high
prevalence of anticipated stigma. As reflected in our par-
ticipants’ reports, HIV-positive individuals fear that
others will be prejudiced against them. In turn, they take
steps to limit who knows of their infection, which then
further reduces the likelihood of encountering discrimin-
atory behaviors [16, 41–43]. Previous qualitative work in
South Africa has similarly found that having fewer phys-
ical symptoms due to treatment helped reduce some
stigma, but that fear of being discovered to be HIV posi-
tive remained [44]. Unfortunately, the efforts to conceal
one’s HIV status can have serious consequences. Most
immediately, a person is able to avoid discrimination
[16, 45], an outcome that desirable and likely reinfor-
cing. But over the longer-term, there are potential dele-
terious mental and physical health impacts. People who
chronically hide their HIV-positive status are more likely
to experience depression, cut off access to valuable
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support resources, and potentially delay needed care
[16, 45, 46].
Our findings contribute to a complex field of study
and serve to explain seemingly divergent trends. Some
studies in Sub-Saharan Africa have found that ART
availability has ‘normalized’ HIV [12–14] while others
have found increases in anticipated stigma despite in-
creased availability of ART [15, 47]. We found that, in
fact, both realities exist. HIV is stigmatized both because
it is a potentially deadly infectious disease and because it
is associated with behaviors traditionally considered
shameful [1]. The introduction of ART has altered the
deadliness of the disease, thereby lessening one driver of
stigma and removing the motivation for some of the
most extreme forms of discrimination (e.g., avoiding
even minimal contact with people living with HIV). It
has not, however, changed the disease’s association with
scorned behavior, which means that prejudicial attitudes
and discriminatory behaviors are still possible. People
with HIV have valid reasons to remain wary of others
learning of their infection. This reality reflects stigma’s
continuing role in perpetuating existing power structures
and social norms, such as placing restrictions over
women’s sexuality and reinforcing masculine norms that
idealize being “healthy and virile” and not needing help
or health care [3, 22].
It is important to note that our data collection
spanned over a year and a half, leading to differences in
how long enhanced access to ART had been available in
different sub-districts. These differences were due both
to how much time had elapsed since the enhanced ART
program officially launched and to the process by which
changes were disseminated. In our study sites, munici-
pals hubs and semi-urban areas tend to implement
health system changes more quickly compared to expan-
sive, rural sites. It is possible that as more time passes in
which ART is available, the relationship between engage-
ment in care and HIV-related stigma may further evolve.
However, without addressing why HIV is stigmatized
and without changing the context in which HIV care is
accessed (which currently can lead to unintended dis-
closure and discrimination), we would expect the rela-
tionship to stay the same.
Implications for HIV prevention and treatment
programming
These results have informed a large-scale comprehensive
HIV prevention program to address social barriers to
prevention and care. Four comprehensive prevention
strategies that were implemented following the situ-
ational analysis include community-based comprehen-
sive health and HIV testing campaigns; support groups
for people living with HIV; health systems strengthening,
including a focus on de-stigmatizing HIV and HIV care;
and community engagement, including training modules
for stigma reduction with key stakeholders. Below we
suggest mechanisms to both reduce stigma and/or to
allow people to access care even in spite of stigma, some
of which we were able to incorporate into our current
programming.
Given the interpersonal and structural dynamics af-
fecting stigma and HIV testing and treatment, interven-
tions that address different facets of the problem are
needed. First and foremost, stigma reduction program-
ming must operate in tandem with the rollout of ART
[48]. In fact, South Africa has already launched a na-
tional stigma reduction campaign and is moving forward
with significant improvements to its HIV care systems
while expanding access for early treatment. Outreach
and training programs have been introduced for health
care facilities; however, programming that includes dis-
cussion around stigma could be extended beyond health
care workers into the general community to help orient
family members and friends to providing support for
loved ones who are HIV-positive. Second, those living
with HIV should be provided with tools to cope with the
discrimination and hostile attitudes that they may en-
counter in daily life, as well as to address internalized
feelings of shame [49]. This can be done through estab-
lishing support groups for people living with HIV/AIDS
(PLHIV) to encourage treatment adherence and to cre-
ate an environment conducive for building social net-
works that can reduce stigma and engender support.
Although this second approach does not necessarily ad-
dress the larger structural problems of stigma in the
community, it is an important stopgap measure to en-
sure that people living with HIV have the needed skills
to enhance their engagement in care and maximize both
HIV and mental health outcomes.
Third, structural shifts in the resources to manage ART
distribution could also help to reduce stigma, along with
enhancing access to care. Currently, the impact of stigma
anticipations on treatment access is exacerbated by health
system capacity problems. Clinics are not able to manage
their patient loads efficiently and confidentially because
they lack sufficient space or trainings in confidentiality-
related best practices. Participants in our study reported
lack of privacy, data management processes that effectively
revealed their HIV status, and lack of trust in providers
maintaining patient confidentiality, which resulted in de-
layed testing and treatment and a greater risk of falling
out of care. This violates both South African and universal
best practices and standards of care to which all patients,
regardless of HIV status, are entitled.
The National Department of Health is currently encour-
aging facilities to have an “integrated” care model (i.e. not
having separate spaces for HIV testing, etc.) and rolling
out an electronic data management system—which in the
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study sub-districts was largely still paper-based at the time
of data collection. When completed, both transitions may
eliminate some current practices that could reveal patients’
HIV status. Modifying existing infrastructure to accommo-
date visual and auditory privacy as more patients seek test-
ing and qualify for care is paramount. Strict policies should
be implemented to secure patient health information [50],
along with prioritizing staff training on confidentiality, sen-
sitivity and stigma reduction. Concerted efforts to rebuild
trust between health facilities and the community could im-
prove access to care [51]. Other studies on stigma in Sub-
Saharan Africa and South Africa have also found that HIV-
related stigma, fear of rejection and stigmatization, lack of
confidence in confidentiality protections and provider mis-
trust result in refusing or delaying HIV counseling and test-
ing services [52–54]. Stigma specifically in healthcare
settings has also been found to be associated with low ac-
cess to care and poorer physical and mental health out-
comes [53, 55, 56]. Addressing these problems is a critical
component of an overall effort to reduce HIV stigma.
Finally addressing and responding to social norms
around how health care is accessed can serve to increase
engagement to care. In line with previous research in
South Africa, we found that HIV stigma intersects with
prevailing norms around healthcare utilization and mas-
culinity. Participants reported and the research team ob-
served that the overwhelming majority of patients at
health facilities were women, children, and the elderly.
This trend was facilitated by the fact that these individ-
uals commonly have non-HIV, non-scorned reasons to
be at a clinic. In a culture where public health is concep-
tualized around women and children, men would have
few health care needs outside of illness. HIV, which
heavily impacts men at an age when they are not likely
to have other chronic conditions, becomes the default
condition associated with men's clinic attendance. Previ-
ous research in South Africa found that men who re-
cently initiated ART felt that seeking care put them at
risk for being labeled as HIV-positive and that men view
public health facilities as women’s spaces [57–59]. To
avoid being labeled as HIV-positive, participants noted
that many men delay care or minimize interaction with
clinics. Traditional ideas of masculinity further exacer-
bate the relationship between stigma, engagement to
care and gender norms. We found that clinic attendance
and illness are interpreted to be signs of weakness and
deviations from the ideal of men as healthy and virile.
Previous research findings from South Africa have also
documented this relationship, and showed that straying
from the traditional ideals of masculinity leads to in-
creased anticipations of stigma and undermines health-
seeking behavior [60–62].
Improving men’s engagement to care in South Africa
is critical—research shows that men test and enter care
later, present with lower CD4 counts, and have worse HIV-
related outcomes than women [63–66]. Re-envisioning
men’s health and reframing conceptualizations of why and
how patients seek care will benefit HIV-related care and
men’s overall wellbeing [67]. We created community work-
shops regarding gender (in addition to the community
workshops on stigma reduction) to engage with men and
women to challenge traditional ideas of masculinity regard-
ing health. This type of programming has already been
shown to increase HIV testing [68–70], and has the poten-
tial to increase engagement in care [71]. Men and youth
need to be able to seek care without raising suspicions that
they are HIV-positive. As described earlier, men at health
facilities near mines were better able to engage in HIV care
as it was delivered as part of work-related health services,
leading to less risk of revealing a person’s status. Indeed, we
designed a portion of our community testing campaigns
specifically to target men—holding confidential testing
events at local mines. Programming for men’s wellness is a
promising approach that merits exploration.
Limitations
The data utilized in this analysis were drawn from a lar-
ger situational analysis intended to broadly understand
the local HIV-related healthcare systems. Although
stigma was not the primary focus of the project at the
outset, it emerged in the course of data collection as a
key theme [22]. As a result, it is possible that our inter-
views and analysis may have missed nuances in how
stigma manifests, as we did not purposefully target HIV-
positive participants for interviews (though many com-
munity members revealed their status in the course of
study participation). Because of our approach, many of
the interviews focused more generally on how individ-
uals in the community responded to stigma, rather than
first person accounts of its effects on a participant’s own
life. Furthermore, our use of focus groups with subset of
participants may have reduced individual’s willingness to
disclose sensitive information. Nonetheless, we believe it
is unlikely to have influenced our findings. There was
strong concordance among what different participants
reported (e.g., patients feared that providers might judge
them for having HIV, some clinic staff reported using ac-
cess to confidential information to figure out if a person
has HIV). There was also strong concordance between
the information that participants reported and what our
study staff directly observed in the process of collecting
data (e.g., participants feared that people may learn of
their HIV status if seeking care, study staff observed
clinic procedures that effectively revealed who is seeking
care for HIV).
Further, our methodology is a rapid, community based
methodology. Inherent to rapid methodologies, there
was limited opportunity to engage with every population
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group in-depth and limited resources to transcribe all in-
terviews. In general, there is always a balance of rigor with
prolonged timelines and additional expense. This process
allowed for extensive qualitative data collection and ana-
lysis over a short period of time. It is also possible that our
purposeful and convenience-based sampling methodology
or only transcribing a small percentage of our interviews
introduced bias into our results. However, the large
amount of data collected, the breadth of data collection
targets and the multi-stage analysis plan, including ana-
lysis in the field and reading all handwritten notes twice,
buffers against extreme bias.
Conclusions
Although significant strides have been made in creating
stigma reduction interventions [72], HIV stigma continues
to be a major barrier to reducing HIV incidence and mor-
tality [53, 73]. As such, reducing stigma, motivating com-
munity members to know their status and engage in care,
and providing tools for individuals and families to support
people living with HIV continue to be foundational to
HIV prevention and care work [74–76]. Prevention and
treatment programming can be made more effective by
identifying how stigma hinders engagement to care and
implementing interventions that specifically address those
factors [77]. Further, efforts to find opportunities to in-
crease access to health care, in spite of stigma, such as en-
suring patient confidentiality and as creating safe spaces
for men and youth to access care, cannot be ignored and
merit further exploration.
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